Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$820,429
+$309,233 QoQ
Shares Held
34,071
+87.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,439
of 2,821 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$3,335,080
PutShares
138,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CREDIT INDUSTRIEL ET COMMERCIAL holds $13,872,333 across 6 Drug Manufacturers - General names. PFE ranks #4 (5.9% of the industry book) .
All Filings in PFE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,335,080 | 138,500 | Put | Defined | 2026-07-24 | |
| 2026-06-30 | $820,429 | 34,071 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $511,196 | 18,205 | Shares | Defined | 2026-04-29 | |
| 2026-03-31 | $3,762,720 | 134,000 | Put | Defined | 2026-04-29 | |
| 2025-12-31 | $3,112,500 | 125,000 | Put | Defined | 2026-02-03 | |
| 2025-12-31 | $863,357 | 34,673 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $2,866,500 | 112,500 | Put | Defined | 2025-11-07 | |
| 2025-09-30 | $1,149,377 | 45,109 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $303,000 | 12,500 | Put | Defined | 2025-08-07 | |
| 2025-03-31 | $253,400 | 10,000 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $185,710 | 7,000 | Put | Defined | 2025-02-24 | |
| No filing history on record for this holder in this stock. | ||||||